Lung Cancers Completed Phase 3 Trials for Bevacizumab (DB00112)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02754882A Study Comparing SB8 and AvastinĀ® in Patients With Advanced Non-squamous Non-small Cell Lung CancerTreatment